Travis E. Grotz, M.D.

Travis E. Grotz, M.D., is a surgical oncologist with clinical and research expertise in both minimally invasive approaches to gastrointestinal malignancies including robotic and laparoscopic cancer surgery; as well as complex, extended resection of advanced soft tissue sarcomas, gastrointestinal cancers and peritoneal metastasis. Dr. Grotz trained at both Mayo Clinic and MD Anderson Cancer Center. He serves as a principal investigator and a co-investigator on several clinical trials at Mayo Clinic, including several trials addressing intraperitoneal therapy. Dr. Grotz serves on the editorial board for the Annals of Surgical Oncology and is a guest editor on numerous other professional journals. He serves on the National Comprehensive Cancer Network (NCCN) guidelines committee for peritoneal mesothelioma, and he serves as a scientific advisor for non-profit organizations such as Mesothelioma Applied Research Foundation and Debbie's Dream Foundation.

Focus areas:

• Gastric or stomach cancer - particularly robotic surgery, innovative reconstructive options such as J-pouches (neo-stomach) and stomach preserving cancer operations such as proximal gastrectomy
• Gastrointestinal stromal tumors (GIST) - both minimally invasive and locally advanced or metastatic
• Peritoneal Mesothelioma
• HIPEC for peritoneal carcinomatosis, and other novel intraperitoneal treatments
• Pseudomyxoma peritonei and appendiceal cancers
• GI cancers including, colon cancer, appendix cancer, carcinoid/neuroendocrine tumors and small bowel tumors
• Retroperitoneal sarcoma